NF-κβ activator 2 |
| Catalog No.GC63104 |
NF-κβ activator 2 inhibits TNF-α-induced canonical NF-κB signaling in PC-3 cells.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2375281-44-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
NF-κβ activator 2 is a potent and orally active NF-?B activator, with an EC50 of 1.58 μM. NF-κβ activator 2 induces SOD2 through increasing NF-?B expression and activation. NF-κβ activator 2 can be used for the research of amyotrophic lateral sclerosis (ALS)[1].
NF-κβ activator 2 (compound 61) (1 μM, 6 h) induces SOD2 mRNA expression in SH-SY5Y neuroblastoma cells[1].
NF-κβ activator 2 (1 mg/kg; i.v.) displays a suitable half-life (0.96 h) in mice[1].NF-κβ activator 2 (5 mg/kg; p.o.) displays a comparable half-life (2.86 h), oral bioavailability (15.6%), and Cmax (92 ng/mL)[1].
[1]. Mathew B, et, al. Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-?B activators for the treatment of ALS. Eur J Med Chem. 2020 Oct 22;112952.
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *